Biovail Enters into Exclusive Promotional Agreement for Zovirax(R).Sciele to Provide Promotional Support for Zovirax[R] Ointment ointment /oint·ment/ (oint´ment) a semisolid preparation for external application to the skin or mucous membranes, usually containing a medicinal substance. oint·ment n. , Zovirax[R] Cream TORONTO -- Biovail Corporation (NYSE NYSE See: New York Stock Exchange :BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency )(TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :BVF) today announced that a subsidiary of the Company (Biovail Pharmaceuticals, Inc.) has entered into an exclusive promotional services agreement with Sciele Pharma, Inc., whereby Sciele's sales force will promote Zovirax[R] Ointment and Zovirax[R] Cream to U.S. physicians. Under the terms of the agreement, which has an initial term of five years, Biovail will compensate Sciele for providing detailing and sampling support for the products. In addition, Sciele is entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: to incentive fees if certain baseline revenue targets are met. A promotional services agreement was contemplated in Biovail's recently issued 2007 financial guidance. As such, no change to Biovail's guidance is necessary. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com. For further information, please contact Ken Howling at 905-286-3000 or send inquiries to ir@biovail.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion